Fibrinolytic activator activity in human neoplasms.
The results of this study suggest that many malignant tumors contain low levels of fibrinolytic activator activity. Evidence is presented to suggest that this low activity may be due to the presence of an inhibitor of fibrinolysis. The presence or absence of measurable fibrinolytic activator activity, and/or inhibitor in neoplastic growths may enable one to predict the probability of viable metastases to a distant site.
D000925:Anticoagulants / Q000494:pharmacology; D001792:Blood Platelets; D005337:Fibrin / Q000494:pharmacology; D005342:Fibrinolysis; D006801:Humans; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000032:analysis* / Q000473:pathology
D000925:Anticoagulants; D005337:Fibrin